Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

✍ Scribed by Susan F. Slovin; Govind Ragupathi; Cristina Musselli; Celina Fernandez; Meghan Diani; David Verbel; Samuel Danishefsky; Philip Livingston; Howard I. Scher

• Book ID: 105966825
• Publisher: Springer-Verlag
• Year: 2005
• Tongue: English
• Weight: 378 KB
• Volume: 54
• Category: Article
• ISSN: 0340-7004
• DOI: 10.1007/s00262-004-0598-5